Science Explorer Back to mapMap
Discussion
Topic · Oncology

Colorectal Cancer Screening and Detection

Colorectal Cancer Screening and Detection is a research topic within Oncology. Science Explorer counts 44k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on global patterns, trends, and research related to colorectal cancer, including screening, colonoscopy, polyps, incidence, mortality, guidelines, risk factors, surveillance, and prevention.

  • Colorectal Cancer
  • Screening
  • Colonoscopy
  • Polyps
  • Incidence
  • Mortality
  • Guidelines
  • Risk Factors
  • Surveillance
  • Prevention
Research works
44k
fractional, since 1950
In the world top 10%
4.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+15%
the tick is no change
Largest producer
United States
37% of the 10 largest, 2022-now
Colorectal Cancer Screening and Detection

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Colorectal Cancer Screening and Detection research?

By volume, the United States and China publish the most (2.7k and 1.6k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.7k works
  2. 2 China 1.6k works
  3. 3 United Kingdom 737 works
  4. 4 Japan 487 works
  5. 5 India 379 works
  6. 6 Italy 336 works
  7. 7 South Korea 295 works
  8. 8 Germany 267 works
  9. 9 Canada 267 works
  10. 10 Spain 244 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 36.7%China: 21.7%United Kingdom: 10.2%Japan: 6.7%6 others listed: 24.7%37%largest
United States2,651 · 36.7%China1,567 · 21.7%United Kingdom737 · 10.2%Japan487 · 6.7%6 others listed1,787 · 24.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Colorectal Cancer Screening and Detection research?

By volume in 2022-now, Harvard University publishes the most Colorectal Cancer Screening and Detection research, followed by Mayo Clinic and Cleveland Clinic.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 101 works
  2. 2 Mayo ClinicUnited States 78 works
  3. 3 Cleveland ClinicUnited States 57 works
  4. 4 Sun Yat-sen UniversityChina 56 works
  5. 5 New York UniversityUnited States 47 works
  6. 6 Imperial College LondonUnited Kingdom 45 works
  7. 7 University of North Carolina at Chapel HillUnited States 45 works
  8. 8 Indiana UniversityUnited States 42 works
  9. 9 University of MichiganUnited States 38 works
  10. 10 Zhejiang UniversityChina 38 works

Who are the leading researchers in Colorectal Cancer Screening and Detection?

The most-cited researchers publishing on Colorectal Cancer Screening and Detection include David Moher, Douglas G. Altman and Ahmedin Jemal.

  1. 1 David Moher Canada 898k citations
  2. 2 Douglas G. Altman United Kingdom 862k citations
  3. 3 Ahmedin Jemal United States 761k citations
  4. 4 Rebecca L. Siegel United States 582k citations
  5. 5 Freddie Bray France 550k citations
  6. 6 Jacques Ferlay France 486k citations
  7. 7 Rob Knight United States 468k citations
  8. 8 Simon Iain Hay United States 452k citations
  9. 9 Theo Vos United States 439k citations
  10. 10 George Davey Smith United Kingdom 435k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Colorectal Cancer Screening and Detection?

The most cited paper in Colorectal Cancer Screening and Detection is "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" (Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al., 2021), with 114,522 citations. Next come "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" (88,280) and "Global cancer statistics" (55,108).

Most cited papers
#PaperReleasedCitations
1 Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2021 114,522
2 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians Open access 12 Sep 2018 88,280
3 Global cancer statistics Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2011 55,108
4 Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Prabhakar Dikshit et al. · International Journal of Cancer Open access 13 Sep 2014 29,250
5 Global cancer statistics, 2012 Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2015 27,467
All 99 most cited papers, with filters and sorting

Where is Colorectal Cancer Screening and Detection research done?

The largest centres of Colorectal Cancer Screening and Detection research in 2022-now are London (United Kingdom), Beijing (China), New York (United States) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 198 works
  2. 2 BeijingChina 191 works
  3. 3 New YorkUnited States 155 works
  4. 4 SeoulSouth Korea 147 works
  5. 5 ShanghaiChina 131 works
  6. 6 TokyoJapan 130 works
  7. 7 GuangzhouChina 107 works
  8. 8 BostonUnited States 92 works
  9. 9 HangzhouChina 82 works
  10. 10 ClevelandUnited States 78 works

Where it is the local speciality

  1. RozzanoIT · 33.9 works22×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Colorectal Cancer Screening and Detection than the world average.

See Colorectal Cancer Screening and Detection on the map

Where is the best place to study Colorectal Cancer Screening and Detection?

Among universities, judged by research, Chinese University of Hong Kong, Humanitas University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.88%fractional works in this field (log) →share of work in the world top 10% →Wuhan UniversityChinese University o…Humanitas UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chinese University of Hong KongChina 73.217.9%5.0×32 +54.3%
2Humanitas UniversityItaly 70.617.3%26.1×34 +173.8%
3Harvard UniversityUnited States 70.015.1%3.5×101 -11.1%
4Wuhan UniversityChina 61.918.5%2.1×26 +75.5%
5Heidelberg UniversityGermany 61.615.6%4.6×31 +6.2%
6King Saud UniversitySaudi Arabia 61.327.6%1.0×9 +87.3%
7Zhejiang UniversityChina 60.818.1%1.6×38 +28.8%
8Sun Yat-sen UniversityChina 59.512.5%3.0×56 +28.9%
9University of MichiganUnited States 57.414.9%2.8×38 +9.5%
10Huazhong University of Science and TechnologyChina 57.121.3%1.3×21 +141.8%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Colorectal Cancer Screening and Detection, country by country

Is Colorectal Cancer Screening and Detection research growing?

Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Colorectal Cancer Screening and Detection.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Colorectal Cancer Screening and Detection as a percentage of every work published that year, 0.044% in 2024.

still counting0.020%0.040%0.060%Colorectal Cancer Screening and Detection0.044% in 202519801990200020102020

Fractional works of Colorectal Cancer Screening and Detection over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Colorectal Cancer Screening and Detection10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Colorectal Cancer Screening and Detection. Posts are plain text and can be reported.